HPV testing in cervical screening

This publication has 76 references indexed in Scilit:

• The Elevated 10-Year Risk of Cervical Precancer and Cancer in Women With Human Papillomavirus (HPV) Type 16 or 18 and the Possible Utility of Type-Specific HPV Testing in Clinical Practice
  JNCI Journal of the National Cancer Institute, 2005
• Human Papillomavirus Type 16 Infections and 2-Year Absolute Risk of Cervical Precancer in Women With Equivocal or Mild Cytologic Abnormalities
  JNCI Journal of the National Cancer Institute, 2005
• Cost-effectiveness of Human Papillomavirus DNA Testing in the United Kingdom, The Netherlands, France, and Italy
  JNCI Journal of the National Cancer Institute, 2005
• Type‐specific associations of human papillomavirus load with risk of developing cervical carcinoma in situ
  International Journal of Cancer, 2004
• The cervical cancer epidemic that screening has prevented in the UK
  The Lancet, 2004
• Against which human papillomavirus types shall we vaccinate and screen? the international perspective
  International Journal of Cancer, 2004
• Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a meta-analysis
  British Journal of Cancer, 2003
• Epidemiologic Classification of Human Papillomavirus Types Associated with Cervical Cancer
  New England Journal of Medicine, 2003
• Host genetic control of HPV 16 titer in carcinoma in situ of the cervix uteri
  International Journal of Cancer, 2002
• High‐risk HPV testing in women with borderline and mild dyskaryosis: long‐term follow‐up data and clinical relevance
  The Journal of Pathology, 2001